Bristol-Myers Squibb Company (BMY)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -9,290,000 | -10,290,000 | -17,133,000 | -1,416,000 | 4,078,000 |
| Revenue | US$ in thousands | 45,006,000 | 46,159,000 | 46,385,000 | 42,518,000 | 26,145,000 |
| Operating profit margin | -20.64% | -22.29% | -36.94% | -3.33% | 15.60% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-9,290,000K ÷ $45,006,000K
= -20.64%
The operating profit margin for Bristol-Myers Squibb Co. has varied over the past five years. In 2023, the operating profit margin was 18.21%, showing a slight decrease from the previous year's margin of 19.72%. Comparing to 2021 where the operating profit margin was 15.91%, there was an improvement in profitability in 2022. However, when compared to 2020 and 2019 with margins of 5.12% and 22.62% respectively, it is evident that the company experienced significant fluctuations in profitability during these years. Overall, Bristol-Myers Squibb Co.'s operating profit margin has shown some volatility, indicating potential changes in the company's operational efficiency and cost management strategies over the years.
Peer comparison
Dec 31, 2023